BiomX Inc. (PHGE) Fair Value 2026

PHGE · Aerospace & Defense ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.0 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (56/100)

Quick Summary — As of 2026-08-28, BiomX Inc. (PHGE) trades at $0.14. QOC: 4.0/10. Value Trap Risk: 56/100 (WARN). 1/13 models active.

Key Facts

Ticker
PHGE
Price
$0.14
Quality Score
4.0/10
Value Trap Risk
56/100
Models Active
1/13
Last Updated
Strength: PWERM suggests +130.6% upside with 34% confidence
Risk: Value Trap score of 56 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give PHGE?

1 Intrinsic Value Models vs. Current Price ($0.14)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $0.32 +130.6%

All Models Active

All 1 models are displayed above.

What Is BiomX Inc. (PHGE) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, BiomX Inc.'s intrinsic value is estimated at a median fair value of $0.32. At a current market price of $0.14, 1 of 1 active valuation models identify upside potential, projecting a median implied return of +130.6%.

What Do the Models Say About PHGE?

1 of 13 models are currently active for PHGE. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does PHGE Rank in Aerospace & Defense?

Among 94 Aerospace & Defense stocks, PHGE ranks #80 by Quality of Company score. CirclFi's QOC score of 4.0/10 evaluates 32 fundamental signals. A score of 4.0 reflects mixed fundamentals.

See all Most Undervalued Aerospace & Defense Stocks →

The Aerospace & Defense sector introduces analytical considerations specific to defense contractor businesses. For BiomX Inc., metrics like program execution margin provide important context that general-purpose valuation models may underweight.

Is PHGE a Value Trap?

CirclFi's Value Trap algorithm assigns PHGE a score of 56/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for BiomX Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, BiomX Inc. scores 4.0 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PHGE valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PHGE's 1 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy BiomX Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Aerospace & Defense Stocks Should You Also Analyze?

11 related Aerospace & Defense stocks with 13-model coverage

CTGLCitrine Global CorpQOC 4.1BLISNAPC Defense IncQOC 4.0MDAMDA Space Ltd.QOC 4.4HAWKHawkEye 360, Inc.QOC 4.0DFNST3 Defense Inc.QOC 4.6SPCXSpace Exploration Technologies Corp.QOC 4.0TDGTransDigm Group IncorporatedQOC 8.7LOARLoar Holdings Inc.QOC 7.6BETABETA Technologies, Inc.QOC 5.9BUKSButler National CorporationQOC 9.4HWMHowmet Aerospace Inc.QOC 9.3

Read investment analysis: CTGL · BLIS · MDA · HAWK · DFNS · SPCX · TDG · LOAR · BETA · BUKS · HWM

Which Other Stocks Have a Similar Quality Score to PHGE?

7 companies across all industries closest to PHGE’s Quality of Company score of 4.0/10.

AMZEAmaze Holdings, Inc.QOC 4.0WEWAWewards, Inc.QOC 4.0HODOHouse of Doge Inc.QOC 4.0EROCERock, Inc.QOC 4.0AIBAIB Data Centers Inc.QOC 4.0OCTVOctave Intelligence plcQOC 4.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AMZE · WEWA · HODO · EROC · AIB · OCTV · NVDA

Where Does PHGE Sit in CirclFi's Aerospace & Defense Rankings?

PHGE is ranked against every other Aerospace & Defense stock CirclFi covers in each of these screens.

See all Aerospace & Defense stocks ranked →

What Else Do Investors Ask About BiomX Inc.’s Valuation?

What is BiomX Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for BiomX Inc. (PHGE). The Quality of Company score is 4.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PHGE overvalued or undervalued right now?

At $0.14, 1 of 1 active models suggest PHGE may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits BiomX Inc.'s business model in Aerospace & Defense.

What does a Quality of Company score of 4.0 mean for PHGE?

BiomX Inc.'s QOC of 4.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on PHGE?

CirclFi analyzes PHGE with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is PHGE a value trap in 2026?

BiomX Inc.'s Value Trap score is 56/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns BiomX Inc. (PHGE) a Quality of Company score of 4.0/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/PHGE/ · Methodology
Primary sources for this PHGE valuation
  • Financial statements: BiomX Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001739174) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PHGE as of ; valuations recomputed .